可吸入的纳米催化疗法用于病毒性肺炎
Wenchang Peng1,2, Wanbo Tai3,4, Bowen Li1
1Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.
Nature materials
|November 26, 2024
概括
一个新的可吸入纳米酶平台有效地减少了肺炎模型中的反应性氧物种和炎症. 这种基于的纳米酶在治疗病毒性肺炎和二次细菌感染方面表现有前途.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 呼吸系统医学 呼吸系统医学
背景情况:
- 肺炎涉及高反应性氧物种 (ROS) 水平,使治疗复杂化.
- 目前用于肺炎的治疗方法面临的挑战是由于肺组织的复杂性和炎症.
研究的目的:
- 开发和评估一种可吸入的纳米酶平台,用于治疗肺炎.
- 评估基于的酸纳米酶在减少氧化应激和炎症方面的有效性.
主要方法:
- 基于的酸纳米酶与自组装结合.
- 在实验室和体内研究中,使用病毒性肺炎的小鼠模型.
- 评估纳米酶内部化,ROS清理,细胞因子减少和巨细胞极化.
主要成果:
- 纳米酶被巨细胞和上皮细胞在炎症部位内化.
- 纳米酶聚合物在病毒性肺炎中降低了ROS水平和炎症性细胞因子的产生.
- 该平台促进了前期治疗 (M2) 巨细胞两极分化.
- 在共感染模型中,纳米酶减轻了细菌炎症并减少了组织损伤.
结论:
- 吸入式纳米酶平台是肺炎治疗的有希望的非侵入性策略.
- 这种方法有效地管理与病毒性和二次细菌性肺炎相关的氧化应激和炎症.
- 纳米酶平台展示了治疗肺炎和相关并发症的潜力.
更多相关视频
10:16Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
3.2K
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
10.7K
相关概念视频
01:23Inhaled Medications
237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
01:28Pneumonia IV: Management
299
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
299